eHIV Review

Undocumented LatinX immigrants are a special population facing many difficulties that hinder their engagement in HIV care and prevention. One obvious barrier is language: many undocumented immigrants do not understand either spoken or written English. Many may have never received routine medical care before and can be baffled by the complexities of the medic...

Better tolerability. More convenient dosing. Less serious side effects. Fewer potential drug-drug interactions. These are some of the most common reasons why individuals living with HIV want or need to change their currently successful ART regimens.  But what do clinicians need to consider when determining which ART to switch to? What role do the patient’s comorbidities play in the...

Do antivirals increase weight gain? Does PrEP reduce the effect of gender-affirming hormone therapy in transgender women?  Join us in the clinic with Dr. Sarah Puryear from the University of California San Francisco as we discuss these important questions.  Take our  post-test  to claim CME credits. Hosted on Acast. See acast.com/privacy...

How can the emergency department become more effective in identifying acute HIV infection? What are the missed opportunities for screening? How can existing protocols be adapted to identify more patients with HIV infection without compromising clinicians’ ability to provide emergent care? Those are some of the questions we’re here to discuss today, with Dr. Douglas White and Dr. Erik Anderson from...

Nearly two of three new HIV infections in the United States appear in transgender women and men who have sex with men (MSM), with most transmission coming from people unaware of their infection. What should clinicians do to increase the rate of HIV screening in these populations to meet guideline recommendations?  In t...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

What do the currently published findings say about the effects of the COVID pandemic on people living with HIV? How is the pandemic affecting patients and clinicians in HIV care delivery and the health of people living with HIV? That’s the dual focus of this  eHIV Review Special Edition  issue. Matthew Spinelli, MD, MAS, assistant professor in the Division o...

Take our  post-test  to claim CME credits. To read a companion newsletter  click here . Why do PWID — people who inject drugs — continue as an uncontrolled source of HIV infection? Where are the missed opportunities for increased screening in this population? What barriers have been identified and what strategies can successfully overcome them...

Take our post-test to claim CME credits. To read a companion newsletter  click here . Both the on-going syphilis and HIV epidemics are highly concentrated among men who have sex with men. While PrEP has been proven to reduce HIV transmission, it is not designed to prevent sexually transmitted infections like gonorrhea, syphilis, and chlamydia. What does...

Take our post-test to claim CME credits. To read a companion newsletter  click here . Our ability to reduce HIV infection and transmission depends on testing, in particular assessing the status of at-risk people who continue to remain untested.   In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania ta...

Take our post-test to claim CME credits. To read a companion newsletter  click here . In the US, nearly half of all people living with HIV are now aged 50 years or older. Their health care providers face new challenges in managing the effects of aging in their patients. In this  e HIV Review podcast, Dr. Maile Young Karris from ...

Take our post-test to claim CME credits. To read a companion newsletter  click here . In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP.  What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population?  What can clinicians do to overcome these barriers?&nb...

Take our post-test to claim CME credits. To read a companion newsletter  click here . People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medica...

Take our post-test to claim CME credits. To read a companion newsletter click here . In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that...

Volume 4, Issue 12 “U=U” — an  U ndetectable HIV viral load means  U ntransmittable HIV virus.  In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Jill Blumenthal from the Division of Infectious Diseases and Global Public Health at the University of California San Diego analyzed the current evidence strongly supporting this concept.  In this Podcast, she discusses “U=U”...

Volume 4, Issue 10 In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness. Take our post-test to claim CME credits. To rea...

Volume 4, Issue 8 While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations. In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses ho...

Volume 4, Issue 6. Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups. In this issue, two of the directors from Boston’s Health Care for the Homeless Program, Dr. Jennifer Brody, Director of HIV Services and ANP Marguerite Beiser, Director of HCV Services, discuss t...

Volume 4, Issue 4. The incidence of the metabolic complications common in people with HIV infection — bone disease, weight gain, cardiovascular disease, and liver disease — is increasing as improved antiretroviral therapies create longer lifespans. In this issue, Dr. Suman Srinivasa and nurse practitioner Kathleen Fitch from Harvard Medical School discuss how to identify and manage these metabolic...

Volume 4, Issue 2. To read a companion newsletter click here . The post New ART Agents: A Clinical Perspective appeared first on DKBmed Radio . Hosted on Acast. See acast.com/privacy for more information.

Volume 3, Issue 8. In this podcast Drs. Allison Agwu evaluates the specific barriers to testing and entering into care among transsexual individuals, migrant and immigrant populations, and adolescents. Take our post-test to claim CME credits. To read a companion newsletter click here . The post In The Clinic: Improving Outcomes in At-Risk Populations appeared first on DKBmed Radio . Hosted on Acas...